Rchr
J-GLOBAL ID:200901089154899773   Update date: Dec. 21, 2024

Yoshimoto Takayuki

ヨシモト タカユキ | Yoshimoto Takayuki
Affiliation and department:
Job title: Professor
Homepage URL  (1): https://immunoreg-web-1.jimdosite.com
Research field  (7): Immunology ,  Functional biochemistry ,  Tumor biology ,  Plastic and reconstructive surgery ,  Nervous system function ,  Dermatology ,  Environmental effects of chemicals
Research keywords  (13): IL-6/IL-12ファミリーサイトカイン ,  IL-27 ,  IL-23 ,  IL-35 ,  Th1/Th2/Th17分化と反応 ,  抗腫瘍免疫誘導 ,  ワクチン ,  無針注射器 ,  造血幹細胞 ,  間葉系幹細胞 ,  歯髄幹細胞 ,  再生医療 ,  アレルギー誘発性評価の動物実験代替法
Research theme for competitive and other funds  (62):
  • 2022 - 2025 不死化したヒト脱落乳歯歯髄幹細胞の培養上清による実験的自己免疫性神経炎の治療効果
  • 2022 - 2025 Development of a new treatment method for repairing intestinal epithelial function of inflammatory bowel disease by human pulp MSC-conditioned medium
  • 2022 - 2025 安全性の高い間葉系幹細胞の細胞フリー療法の開発:培養上清の抗腫瘍効果
  • 2022 - 2025 新規無針注入器によるDNA・蛋白質の皮内投与によるワクチン効果と遺伝子治療増強
  • 2021 - 2024 不死化したヒト乳歯歯髄幹細胞の培養上清の基礎的解析と褥瘡マウスモデルの治療効果
Show all
Papers (205):
  • Yasuhiro Katahira, Jukito Sonoda, Miu Yamagishi, Eri Horio, Natsuki Yamaguchi, Hideaki Hasegawa, Izuru Mizoguchi, Takayuki Yoshimoto. Topical Application of Cha-Koji, Green Tea Leaves Fermented with Aspergillus Luchuensis var Kawachii Kitahara, Promotes Acute Cutaneous Wound Healing in Mice. Scientia Pharmaceutica. 2024. 92. 3. 44-44
  • Hisashi Nagase, Takuma Kato, Takayuki Yoshimoto. State-of-the-Art Cancer Immunotherapies. International journal of molecular sciences. 2024. 25. 5
  • Ikuya Tanabe, Kunitaka Yoshida, Shinkichi Ishikawa, Kanae Ishimori, Tsuneo Hashizume, Takayuki Yoshimoto, Takao Ashikaga. Development of an In Vitro Sensitisation Test Using a Coculture System of Human Bronchial Epithelium and Immune Cells. Alternatives to laboratory animals : ATLA. 2023. 51. 6. 387-400
  • Toshihiko Yoneto, Kenichiro Hasumi, Nobukazu Takahashi, Nastuki Seki, Yasutaka Takeda, Takayuki Yoshimoto. Long-lasting complete remission in a patient with systemic metastases of recurrent breast cancer treated with cyclin-dependent kinases 4/6 inhibitors: a case report. Journal of Medical Case Reports. 2023. 17. 1. 190-190
  • Jukito Sonoda, Izuru Mizoguchi, Shinya Inoue, Aruma Watanabe, Ami Sekine, Miu Yamagishi, Satomi Miyakawa, Natsuki Yamaguchi, Eri Horio, Yasuhiro Katahira, et al. A Promising Needle-Free Pyro-Drive Jet Injector for Augmentation of Immunity by Intradermal Injection as a Physical Adjuvant. International Journal of Molecular Sciences. 2023
more...
MISC (159):
more...
Patents (14):
Books (3):
  • Modification of tumor cells with Fas(CD95)antigen gene and Fas ligand(CD95L)gene transfection by electroporation for immunotherapy of cancer.
    Cancer Immunotherapy Protocols. Humana Press, Belgium, in press. 1999
  • MTV-Encoded Superantigen Expression in B Lymphoma Cells in SJL Mice as A Stimulus for "Reversed Immunological Surveillance"
    Superantigens : A Pathogen's View of the Immune System 1993
  • Synthetic Polymer-Protein Hybrids : Modification of L-Asparaginase with Polyethylene Glycol
    Multiphase Biomedical Materials (VNU Science Press) 1989
Education (3):
  • 1986 - 1989 Tokyo Institute of Technology Graduate School, Division of Natural Science
  • 1984 - 1986 Tokyo Institute of Technology
  • 1980 - 1984 Tokyo Institute of Technology Faculty of Science
Professional career (2):
  • (BLANK)
  • (BLANK)
Work history (6):
  • 2010/12 - 現在 Tokyo Medical University
  • 2008/06 - 2010/11 Tokyo Medical University
  • 2000/01 - 2008/05 Tokyo Medical University
  • 1992/04 - 1999/12 The University of Tokyo
  • 1989/04 - 1992/03 New ork University Medical Center Department of Pathology (Prof. Daniel Meruelo) ポスドク
Show all
Committee career (4):
  • 2024/11 - 現在 日本再生医療学会、代議員
  • 2014/06 - 現在 日本インターフェロン・サイトカイン学会 幹事
  • 2013/10 - 現在 日本癌学会 評議員
  • 2005/01 - 現在 日本免疫学会 評議員
Association Membership(s) (5):
日本免疫学会 ,  日本インターフェロン・サイトカイン学会 ,  日本再生医療学会 ,  日本動物実験代替法学会 ,  日本癌学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page